147 related articles for article (PubMed ID: 25797291)
1. Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice.
Han JH; Park JH; Kim BY; Chang SN; Kim TH; Park JH; Kim DJ
J Vet Sci; 2015; 16(3):281-7. PubMed ID: 25797291
[TBL] [Abstract][Full Text] [Related]
2. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
[TBL] [Abstract][Full Text] [Related]
3. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
5. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
6. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
Jain AK; Raina K; Agarwal R
Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of C-CAM cell adhesion molecule in prostate carcinogenesis in a transgenic mouse model.
Pu YS; Luo W; Lu HH; Greenberg NM; Lin SH; Gingrich JR
J Urol; 1999 Sep; 162(3 Pt 1):892-6. PubMed ID: 10458403
[TBL] [Abstract][Full Text] [Related]
8. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
[TBL] [Abstract][Full Text] [Related]
9. Androgen-independent prostate cancer progression in the TRAMP model.
Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM
Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
11. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
Tepaamorndech S; Huang L; Kirschke CP
Cancer Lett; 2011 Sep; 308(1):33-42. PubMed ID: 21621325
[TBL] [Abstract][Full Text] [Related]
12. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
[TBL] [Abstract][Full Text] [Related]
14. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
15. Effect of Low-Fat Diet in Obese Mice Lacking Toll-like Receptors.
Rau CS; Wu SC; Lu TH; Wu YC; Wu CJ; Chien PC; Kuo PJ; Lin CW; Tsai CW; Hsieh CH
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30304787
[No Abstract] [Full Text] [Related]
16. Relaxin promotes prostate cancer progression.
Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
[TBL] [Abstract][Full Text] [Related]
17. Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
Gatti G; Quintar AA; Andreani V; Nicola JP; Maldonado CA; Masini-Repiso AM; Rivero VE; Maccioni M
Prostate; 2009 Sep; 69(13):1387-97. PubMed ID: 19496069
[TBL] [Abstract][Full Text] [Related]
18. A microRNA/Runx1/Runx2 network regulates prostate tumor progression from onset to adenocarcinoma in TRAMP mice.
Farina NH; Zingiryan A; Akech JA; Callahan CJ; Lu H; Stein JL; Languino LR; Stein GS; Lian JB
Oncotarget; 2016 Oct; 7(43):70462-70474. PubMed ID: 27634876
[TBL] [Abstract][Full Text] [Related]
19. Short- and long-term regulation of intestinal Na+/H+ exchange by Toll-like receptors TLR4 and TLR5.
Cabral JM; Grácio D; Soares-da-Silva P; Magro F
Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(8):G703-15. PubMed ID: 26294670
[TBL] [Abstract][Full Text] [Related]
20. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis.
Ortega-Cava CF; Ishihara S; Rumi MA; Aziz MM; Kazumori H; Yuki T; Mishima Y; Moriyama I; Kadota C; Oshima N; Amano Y; Kadowaki Y; Ishimura N; Kinoshita Y
Clin Vaccine Immunol; 2006 Jan; 13(1):132-8. PubMed ID: 16426010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]